Schedule 13D ownership disclosure
Intiva BioPharma Inc.
Security class unavailable · CUSIP: 46116E103
Event date: 2019-04-04
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 19,000,000
- Percent of class
- 35.3700%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001144204-19-023071
- Form type
- SC 13D
- Filer
- Kanativa USA Inc.
- CIK
- CIK 1719804
- Filed
- May 02, 2019
- Reporting period
- Apr 04, 2019
- Description
- Schedule 13D beneficial ownership